Sclerosing encapsulating peritonitis: Primary and secondary forms

Journal of Clinical Gastroenterology

Volumn 22, Issue 1, 1996, Pages 54-57

  Cohen, O ^a   Abrahamson, J ^a   Ben Ari, J ^a   Frajewicky, V ^a   Eldar, S ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Intestinal obstruction; Peritoneum; Sclerosing peritonitis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; HEMODIALYSIS; HEMOPERITONEUM; HUMAN; LAPAROTOMY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SCLEROSING PERITONITIS; SMALL INTESTINE OBSTRUCTION;

ADULT; DIAGNOSIS, DIFFERENTIAL; HUMANS; INTESTINAL OBSTRUCTION; MALE; PERITONEUM; PERITONITIS; SCLEROSIS;

EID: 0030046972     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199601000-00016     Document Type: Article

References (46)

1. Brown P, Baddeley H, Read AE, Davies JD, McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic blocking drug (practolol). Lancet 1974;2:1477-81.
2. Gandhi VS, Hymayun HM, Ing TS, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980;140:1201-1203.
3. Owtschinnikow PJ. Peritonitis chronica fibrosa incapsulata. Arch Klin Chir 1907;83:623-634.
4. Winner P. Ueber Zuckergussdarm (peritonitis chronica fibrosa incapsulata). Beitr Klin Chir 1921;123:72-81.
5. Hartmann W. Peritonitis fibroplastica. Dtsch Z Chir 1942;255: 173-82.
6. Trudinger BJ, Fitchett DH. Practolol peritonitis presenting as a pelvic mass. Br J Obstet Gynecol 1976;83:326-8.
7. Harty RF. Sclerosing peritonitis and propranolol. Arch Intern Med 1978;138:1424-6.
8. Denis J, Paineau J, Potel G, Fontenaille C, Guenel J. Continuous ambulatory peritoneal dialysis [Letter]. Ann Intern Med 1980;93:508.
9. Korzets A, Korzets Z, Peer G, et al. Sclerosing peritonitis. Am J Nephrol 1988;8:143-6.
10. Foo KT, Ng KC, Rauff A, Foong WC, Sinniah R. Unusual small intestinal obstruction in adolescent girls: the abdominal cocoon. Br J Surg 1978;65:427-30.
11. Sayfan J, Adam YG, Reif R. Peritoneal encapsulation in childhood. Am J Surg 1979;138:725-7.
12. Marinho A, Adelusi B. The abdominal cocoon: case report. Br J Obstet Gynecol 1980;87:249-50.
13. Sieck JO, Cowgill R, Larkworthy W. Peritoneal encapsulation and abdominal cocoon. Gastroenterology 1983;84:1597-601.
14. Dehn TBC, Lucas MG, Wood RFM. Idiopathic sclerosing peritonitis. Postgrad Med J 1985;61:841-2.
15. Narayanan R, Kabra SG, Bhargava BN, Sangal BC. Idiopathic sclerosing encapsulating peritonitis. Lancet 1989;2:127-9.
16. Lee RG. Sclerosing peritonitis. Dig Dis Sci 1989;34:1473-6.
17. Burstein M, Galun E, Ben-Chetrit E. Idiopathic sclerosing peritonitis in a man. J Clin Gastroenterol 1990;12:698-701.
18. Tsunoda T, Mochinaga N, Eto T, Furui J, Tomioka T, Takahara H. Sclerosing encapsulating peritonitis combined with peritoneal encapsulation. Arch Surg 1993;128:353-5.
19. LaFerla G, McColl KEL, Crean GP. CSF induced sclerosing peritonitis: a new entity? Br J Surg 1986;73:7.
20. Ngo Y, Messing B, Marteau P, et al. Peritoneal sarcoidosis: an unrecognized cause of sclerosing peritonitis. Dig Dis Sci 1992;37:1776-80.
21. Black B, Nelson D, Walker W. Multifocal subperitoneal sclerosis. Surgery 1968;68:706-10.
22. Andrion A, Pira E, Mollo F. Peritoneal plaques and asbestos exposure. Arch Pathol Lab Med 1983;107:609-10.
23. Cosh J, Cates JE. Pugh DW. Carcinoid heart disease. Br Heart J 1959;21:369-80.
24. Sohar E, Gafin J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227-53.
25. Greenlee HB, Stanley MM, Reinhardt GF, Chejfec G. Small bowel obstruction from compression and kinking of intestine by thickened peritoneum in cirrhotics with ascites treated with LeVeen shunt [Abstract]. Gastroenterol 1979;76:1282.
26. Raftery EB, Denman AM. Systemic lupus erythematosus syndrome induced by Practolol. Br Med J 1973;2:452-5.
27. Moss J, Berg RA, Baum BJ, Crystal RG. In vitro model for fibrosis induced by beta-adrenergic blockers: propranolol inhibits beta-adrenergic suppression of collagen production by human fibroblasts. Clin Res 1979;27:445.
28. Ahmad S. Sclerosing peritonitis and propranolol. Chest 1981; 79:361-2.
29. Marshall AJ, Baddeley H, Barritt DW, et al. Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers. Q J Med 1977;46: 135-49.
30. Shaldon S, Koch KM, Quellhorst E, Dinarello CA. Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs 1984;30:193-4.
31. Mion CM, Boen ST. Analysis of factors responsible for formation of adhesions during chronic peritoneal dialysis. Am J Med Sci 1965;250:675-9.
32. Schmidt RW, Blumenkrantz M. Peritoneal sclerosis - a 'sword of Damocles' for peritoneal dialysis? Arch Intern Med 1981;141: 1265-7.
33. Ellis H. Intraperitoneal adhesions. Br J Hosp Med 1974;11:401-8.
34. Faller B, Marichal JF. Loss of ultrafiltration in CAPD: a role for acetate. Periton Dial Bull 1984;4:10-3.
35. Tenckhoff H. Chronic peritoneal dialysis. A manual for patients, personnel and physicians. Seattle: University of Washington School of Medicine, 1974:57-61.
36. Bingswanger U, Banmatter F, Keusch G, Schiffi H, Koller M. Chemical peritonitis during chronic ambulatory peritoneal dialysis? In: Legrain M, ed. Continuous ambulatory peritoneal dialysis. Amsterdam: Excerpta Medica, 1980:238-44.
37. Lasker N, Burke JF, Patchefsky A. Peritoneal reactions to particulate matter in peritoneal dialysis solutions. Trans Am Soc Artif Intern Organs 1975;21:342-5.
38. Verger C, Celicout B. Peritonitis permeability and encapsulating peritonitis. Lancet 1985;1:986-7.
39. Backenroth-Maayan R, Longnecker R, Kabosos D. Failure of the peritoneal membrane during chronic intermittent peritoneal dialysis. In: Gahl GM, Kessel M, Nolph KD, eds. Advances in peritoneal dialysis. Proceedings of the 2nd International Symposium on Peritoneal Dialysis, Berlin 1981, International Congress Series 567. Amsterdam: Excerpta Medica, 1981:208-13.
40. Slingeneyer A, Mion C, Mourad G, Canaud B, Faller B, Beraud JJ. Progressive sclerosing peritonitis: a late and severe complication of maintenance peritoneal dialysis. Trans Am Soc Artif Intern Organs 1983;29:633-8.
41. Bradley JA, McWhinnie DL, Hamilton DNH, et al. Sclerosing obstructive peritonitis after CAPD. Lancet 1983;2:113-4.
42. Hollman AS, McMillan MA, Briggs JD, Junor BJR, Morley P. Ultrasound changes in sclerosing peritonitis following continuous ambulatory peritoneal dialysis. Clin Radiol 1991;43: 176-9.
43. Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J 1975;1:595-8.
44. Kittur DS, Korpe SW, Raytch RE, Smith GW. Surgical aspects of sclerosing encapsulating peritonitis. Arch Surg 1990;125: 1626-8.
45. Baxter-Smith DC, Monypenny IJ, Dorricott NJ. Sclerosing peritonitis in patient on timotol. Lancet 1978;2:149.
46. Jackson BT. Surgical treatment of sclerosing peritonitis caused by practolol. Br J Surg 1977;64:255-7.